Andrew McKay

4.1k total citations · 1 hit paper
58 papers, 2.0k citations indexed

About

Andrew McKay is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Andrew McKay has authored 58 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 16 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Andrew McKay's work include Cutaneous Melanoma Detection and Management (11 papers), Autoimmune and Inflammatory Disorders Research (6 papers) and Ocular Diseases and Behçet’s Syndrome (6 papers). Andrew McKay is often cited by papers focused on Cutaneous Melanoma Detection and Management (11 papers), Autoimmune and Inflammatory Disorders Research (6 papers) and Ocular Diseases and Behçet’s Syndrome (6 papers). Andrew McKay collaborates with scholars based in United Kingdom, United States and Singapore. Andrew McKay's co-authors include C W Imrie, Jennifer O’Neill, Leslie H. Blumgart, I S Benjamin, J. Ferguson, Anthony G Marson, Iain Mackenzie, Jennifer Weston, Naghme Adab and Rebecca Bromley and has published in prestigious journals such as New England Journal of Medicine, The Lancet and PLoS ONE.

In The Last Decade

Andrew McKay

57 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis

1978 390 citations Andrew McKay et al. British journal of surgery profile →

Peers

Countries citing papers authored by Andrew McKay

Since Specialization

Citations

This map shows the geographic impact of Andrew McKay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew McKay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew McKay more than expected).

Fields of papers citing papers by Andrew McKay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew McKay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew McKay. The network helps show where Andrew McKay may publish in the future.

Co-authorship network of co-authors of Andrew McKay

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew McKay. A scholar is included among the top collaborators of Andrew McKay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew McKay. Andrew McKay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Assessing a single-cell multi-omic analytic platform to characterize ex vivo-engineered T-cell therapy products 2024 ·Frontiers in Bioengineering and Biotechnology ·Maryam Moshref, (unknown), Andrew McKay, Julien Camperi, (unknown), Norikiyo Ueno, Shu Wang, (unknown), Somayeh S. Tarighat, Steffen Durinck, Ho‐Young Lee, Dayue Chen	2
2	Addressing discipline specificity in a multidisciplinary EAP classroom through data-driven learning 2024 ·Durham Research Online (Durham University) ·(unknown), Andrew McKay	1
3	Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial 2020 ·The Lancet Rheumatology ·Athimalaipet V Ramanan, Andrew D. Dick, Catherine Guly, Andrew McKay, Ashley P Jones, Ben Hardwick, Richard Lee, Matthew D. Smyth, Thomas Jaki, Michael W. Beresford	76
4	Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT 2019 ·Health Technology Assessment ·Athimalaipet V Ramanan, Andrew D. Dick, Ashley P Jones, Dyfrig Hughes, Andrew McKay, Anna Rosala‐Hallas, Paula Williamson, Ben Hardwick, Helen Hickey, Naomi Rainford, Graeme L. Hickey, Ruwanthi Kolamunnage‐Dona, (unknown), Catrin Plumpton, Eifiona Wood, Sandrine Compeyrot‐Lacassagne, Patricia Woo, Clive Edelsten, Michael W. Beresford	20
5	Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation 2019 ·BMJ ·Joanne Blair, Andrew McKay, Colin Ridyard, (unknown), Emma Bedson, Matthew Peak, Mohammed Didi, Francesca Annan, John W Gregory, Dyfrig Hughes, Carrol Gamble	48
6	A phase II trial protocol of Tocilizumab in anti-TNF refractory patients with JIA-associated uveitis (the APTITUDE trial) 2018 ·BMC Rheumatology ·(unknown), Athimalaipet V Ramanan, Andrew D. Dick, Ashley P Jones, Catherine Guly, Ben Hardwick, Helen Hickey, Richard Lee, Andrew McKay, Michael W. Beresford	23
7	Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis 2017 ·New England Journal of Medicine ·Athimalaipet V Ramanan, Andrew D. Dick, Ashley P Jones, Andrew McKay, Paula Williamson, Sandrine Compeyrot‐Lacassagne, Ben Hardwick, Helen Hickey, Dyfrig Hughes, Patricia Woo, Diana Benton, Clive Edelsten, Michael W. Beresford	238
8	Measurement of HbA1c in multicentre diabetes trials – should blood samples be tested locally or sent to a central laboratory: an agreement analysis 2016 ·Trials ·Barbara Arch, Joanne Blair, Andrew McKay, John W Gregory, Paul Newland, Carrol Gamble	7
9	Opening research sites in multicentre clinical trials within the UK: a detailed analysis of delays 2014 ·BMJ Open ·Anna Kearney, Andrew McKay, Helen Hickey, Silviya Balabanova, Anthony G Marson, Carrol Gamble, Paula Williamson	17
10	Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child 2014 ·Cochrane Database of Systematic Reviews ·Rebecca Bromley, Jennifer Weston, Naghme Adab, J Greenhalgh, (unknown), Andrew McKay, Catrin Tudur Smith, Anthony G Marson	192
11	Variation in the prevalence of chronic bronchitis among smokers: a cross-sectional study 2014 ·The International Journal of Tuberculosis and Lung Disease ·P A Mahesh, (unknown), Sindaghatta Krishnarao Chaya, (unknown), Andrew McKay, (unknown), Utz Johann Pape	15
12	What Parents of Children Who Have Received Emergency Care Think about Deferring Consent in Randomised Trials of Emergency Treatments: Postal Survey 2012 ·PLoS ONE ·Carrol Gamble, Simon Nadel, Dee Snape, Andrew McKay, Helen Hickey, Paula Williamson, Linda Glennie, Claire Snowdon, Bridget Young	36
13	Should Pre-operative Troponin be a Standard Requirement in Patients Undergoing Major Lower Extremity Amputation? 2006 ·European Journal of Vascular and Endovascular Surgery ·Simon C. Gibson, (unknown), Colin Berry, Christopher J. Payne, (unknown), Paul N. Rogers, Andrew McKay, H. J. Dargie, David Kingsmore	18
14	Revalidation — are we fixing a system that wasn't broken? 2003 ·The Surgeon ·Andrew McKay	2
15	Surgical management of malignant melanoma 1997 ·British journal of surgery ·Andrew McKay	4
16	A comparison of dosinietric methods in isolated limb perfusion with melphalan for malignant melanoma of the lower extremity 1996 ·European Journal of Cancer ·(unknown), Andrew McKay, (unknown), R.M. MacKie	3
17	Clinical experience of carbon dioxide laser ablation for cutaneous limb recurrences from malignant melanoma 1994 ·(unknown), Andrew McKay	3
18	Penetrating abdominal stab wounds: a plea for a more conservative policy 1989 ·Injury ·Robert C. McIntyre, C D Auld, R J Cuschieri, Ian Taggart, Andrew McKay	10
19	A double blind randomised placebo controlled trial of hexopal in primary Raynaud's disease 1988 ·Clinical Rheumatology ·G T Sunderland, J. J. F. Belch, R D Sturrock, C.D. Forbes, Andrew McKay	18
20	Topical reviews in vascular surgery 1982 ·John G. Pollock, Andrew McKay	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact